Medicines not evaluated properly in J-K: Drugs CGI

Image
Press Trust of India Srinagar
Last Updated : May 05 2013 | 3:00 PM IST
Drugs Controller General of India G N Singh today admitted that evaluation of medicines in Jammu and Kashmir is "not done properly", but maintained that the centre was serious about curbing procurement and sale of spurious drugs in the state.
"Evaluation of drugs is not done properly, but we will take steps to check spurious drugs," Singh told reporters here before leaving for New Delhi.
Singh said the centre is making "concerted efforts" to check the quality and efficacy of drugs in the state.
"We are very serious and are making concerted efforts to check for the quality, safety and efficacy of drugs in the state especially in Kashmir Valley. Central government is fair... Our team has clear directions from the centre to check for any spurious drugs in the state," he said.
Singh said if there are any fake drugs, they will be "thrown out" and people responsible will be "jailed".
He said the Pharmacy Act is not being "uniformly implemented" and assured changes will be made to make it "more effective" and "at par with the rest of the country".
"We will make sure that medicines save lives and not take them," he said.
Singh said a modern drug testing laboratory will be set up in the state and all facilities will be provided to curb the sale of spurious drugs.
"We will set up a state-of-the-art lab for testing here. And till that, we are going to provide facilities for checking the drugs in other labs and provide faster reports," he said.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 05 2013 | 3:00 PM IST

Next Story